This topic contains a solution. Click here to go to the answer

Author Question: Lesions of the amygdala in monkeys usually results in a. reductions in fear and anxiety. b. ... (Read 66 times)

strangeaffliction

  • Hero Member
  • *****
  • Posts: 660
Lesions of the amygdala in monkeys usually results in
 
  a. reductions in fear and anxiety.
 b. increased aggression.
 c. increased fear.
 d. no observable changes in emotional behavior, although learning is impaired.

Question 2

The emotional symptoms of Klver-Bucy syndrome probably result from damage to the
 
  a. amygdala.
 b. orbitofrontal cortex.
 c. septal area.
 d. temporal lobe cortex.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

chjcharjto14

  • Sr. Member
  • ****
  • Posts: 342
Answer to Question 1

a

Answer to Question 2

a




strangeaffliction

  • Member
  • Posts: 660
Reply 2 on: Jun 21, 2018
Excellent


Joy Chen

  • Member
  • Posts: 354
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

A good example of polar molecules can be understood when trying to make a cake. If water and oil are required, they will not mix together. If you put them into a measuring cup, the oil will rise to the top while the water remains on the bottom.

Did you know?

Excessive alcohol use costs the country approximately $235 billion every year.

Did you know?

Autoimmune diseases occur when the immune system destroys its own healthy tissues. When this occurs, white blood cells cannot distinguish between pathogens and normal cells.

Did you know?

Before a vaccine is licensed in the USA, the Food and Drug Administration (FDA) reviews it for safety and effectiveness. The CDC then reviews all studies again, as well as the American Academy of Pediatrics and the American Academy of Family Physicians. Every lot of vaccine is tested before administration to the public, and the FDA regularly inspects vaccine manufacturers' facilities.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library